Testing effectiveness (Phase 2)Ended earlyNCT00946023
What this trial is testing
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
Who this might be right for
LymphomaB-cell LymphomaNon Hodgkin Lymphoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 135